Position in NVS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$6,112
+$736 QoQ
Shares Held
39
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,560
of 1,603 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARYLAND CAPITAL ADVISORS INC. holds $1,214,787 across 12 Drug Manufacturers - General names. NVS ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,448 | $367,747 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,577 | $331,144 | |
| 3 | AMGN |
Amgen Inc
|
698 | $252,759 | |
| 4 | ABBV |
AbbVie Inc.
|
963 | $242,329 | |
| 5 | AZN |
Astrazeneca PLC
|
38 | $7,205 | |
| 6 | NVS |
Novartis AG
This page
|
39 | $6,112 | |
| 7 | OGN |
Organon & Co.
|
253 | $3,425 | |
| 8 | LLY |
ELI LILLY & Co
|
2 | $2,398 |
All Filings in NVS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,112 | 39 | Shares | Sole | 2026-07-17 | |
| 2025-12-31 | $5,376 | 39 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $5,001 | 39 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $4,719 | 39 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $4,347 | 39 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,795 | 39 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $4,945 | 43 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $4,684 | 44 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $5,513 | 57 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $15,145 | 150 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $15,279 | 150 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $15,136 | 150 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $13,800 | 150 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $13,608 | 150 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $16,418 | 216 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $18,258 | 216 | Shares | Sole | 2022-07-25 | |
| No filing history on record for this holder in this stock. | ||||||